The 10-second takeaway
For the quarter ended June 30 (Q2), Innophos Holdings met expectations on revenue and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue improved and GAAP earnings per share dropped significantly.
Margins contracted across the board.
Innophos Holdings chalked up revenue of $214.2 million. The four analysts polled by S&P Capital IQ predicted net sales of $215.2 million on the same basis. GAAP reported sales were 6.2% higher than the prior-year quarter's $201.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.81. The five earnings estimates compiled by S&P Capital IQ predicted $0.89 per share. GAAP EPS of $0.73 for Q2 were 21% lower than the prior-year quarter's $0.92 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 19.8%, 460 basis points worse than the prior-year quarter. Operating margin was 12.3%, 390 basis points worse than the prior-year quarter. Net margin was 7.7%, 260 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $215.7 million. On the bottom line, the average EPS estimate is $0.96.
Next year's average estimate for revenue is $879.5 million. The average EPS estimate is $3.72.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 809 members out of 832 rating the stock outperform, and 23 members rating it underperform. Among 239 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 233 give Innophos Holdings a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Innophos Holdings is outperform, with an average price target of $59.25.
Over the decades, small-cap stocks like Innophos Holdings have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: 2 Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Innophos Holdings to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why NewLink Genetics, Harmonic, and Innophos Holdings Slumped Today
These stocks helped lead the market lower. Find out why.
Why Shares of Innophos Holdings, Inc. Jumped Today
Is this meaningful or just another movement?
5 Stocks Growing Their Dividends by 30% Per Year
If you’d like to boost your dividend income, take a look at these stocks.